Stock & Company Details
DiaMedica Therapeutics Inc $DMAC
Price:
N/A
N/A
54M
$530M
52 Week High:
N/A
10 Day Average Volume:
N/A
-13.48
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
DMAC technical indicators
Latest DiaMedica Therapeutics Inc (DMAC) indicator readings as of 2026-10-29.
DMAC's 14-day RSI is 67.9, in neutral territory. At $9.52 it is trading 34.0% above its 200-day moving average of $7.11, and above its 50-day average of $7.55. Price sits above the upper Bollinger Band ($7.27 to $9.50). ADX reads 33.9, indicating a trending market.
Overview
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
Finance Bot
Ask your questions
Start by typing a question below.
